Status: open

Endo; Teikoku; Watson (Lidoderm)

Defendant: Endo; Teikoku; Watson

Consumers who bought certain dosages of Lidoderm and/or its generic version between August 23, 2012 and August 1, 2014 may be eligible for payment. The companies reached a settlement over allegations of antitrust violations. 

Claim Deadline: Monday, 01 October 2018.